Showing 1 - 5 results of 5 for search 'Thinkhamrop B', query time: 0.02s
Refine Results
-
1
Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma Correlated with HER2 Overexpression by Titapun A, Techasen A, Sa-Ngiamwibool P, Sithithaworn P, Luvira V, Srisuk T, Jareanrat A, Dokduang H, Loilome W, Thinkhamrop B, Khuntikeo N
Published 2020-11-01
Article -
2
Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiori... by Chetchotisakd, P, Anunnatsiri, S, Mootsikapun, P, Wongrattanacheewin, S, Chierakul, W, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S, Chaowagul, W, Phimda, K, Phiphitaporn, S, Chaisuksant, S, Susaengrat, W, Pilaikul, J, Toondee, C, Thinkhamrop, B
Published 2014Journal article -
3
Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferior... by Chetchotisakd, P, Chierakul, W, Chaowagul, W, Anunnatsiri, S, Phimda, K, Mootsikapun, P, Chaisuksant, S, Pilaikul, J, Thinkhamrop, B, Phiphitaporn, S, Susaengrat, W, Toondee, C, Wongrattanacheewin, S, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S
Published 2014Journal article -
4
Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiori... by Chetchotisakd, P, Anunnatsiri, S, Mootsikapun, P, Wongrattanacheewin, S, Chierakul, W, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S, Chaowagul, W, Phimda, K, Phiphitaporn, S, Chaisuksant, S, Susaengrat, W, Pilaikul, J, Toondee, C, Thinkhamrop, B
Published 2014Journal article -
5
High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection by Titapun A, Luvira V, Srisuk T, Jareanrat A, Thanasukarn V, Thanee M, Sa-Ngiamwibool P, Padthaisong S, Duangkumpha K, Suksawat M, Loilome W, Sithithaworn P, Techasen A, Thinkhamrop B, Dzienny A, Caglayan A, Park D, Mahmud S, Khuntikeo N
Published 2021-06-01
Article